MedTrace Logo

Impact of Ascorbic Acid on Post-Cardiothoracic Surgery Inflammation

NCT00519337 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2012-01-05

No results posted yet for this study

Summary

The purpose of this study is to see if ascorbic acid (Vitamin-C) therapy will reduce inflammation following heart surgery.

Conditions

Interventions

DRUG

Ascorbic acid

Ascorbic acid, 2 g p.o. the night before surgery followed by 500mg B.I.D. for 4 post-operative days

DRUG

Placebo

Placebo capsule, 4 capsules the night before surgery followed by 1 capsule B.I.D. for 4 postoperative days

Sponsors & Collaborators

  • The Gustavus and Louise Pfeiffer Research Foundation

    collaborator UNKNOWN

  • Hartford Hospital

    lead OTHER

Principal Investigators

  • C. Michael White, Pharm.D. · Hartford Hospital, University of Connecticut

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2009-10-31
Completion
2011-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00519337 on ClinicalTrials.gov